These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Papaverine hydrochloride as therapy for mentally confused geriatric patients. LaBrecque DC Curr Ther Res Clin Exp; 1966 Mar; 8(3):106-9. PubMed ID: 4956578 [No Abstract] [Full Text] [Related]
5. A trial of lipotropic enzymes in atheromatous ("arteriosclerotic") dementia. Hall P; Harcup M Angiology; 1969 May; 20(5):287-300. PubMed ID: 4976740 [No Abstract] [Full Text] [Related]
6. Experiences in the management of geriatric patients with chronic brain syndrome. Green I Am J Psychiatry; 1965 Nov; 122(5):586-9. PubMed ID: 5835835 [No Abstract] [Full Text] [Related]
7. [Clinical experience with treatment by piracetam in gerontopsychiatry (author's transl)]. Vencovský E; Hronek J; Drahokoupil L; Fait V; Hudcová T; Laciga Z; Vanková H Cesk Psychiatr; 1980 Apr; 76(2):89-97. PubMed ID: 6994907 [No Abstract] [Full Text] [Related]
8. Mental decline in the elderly: pharmacotherapy (ergot alkaloids versus papaverine). Rosen HJ J Am Geriatr Soc; 1975 Apr; 23(4):169-74. PubMed ID: 803997 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of EEG and clinical changes associated with pavabid therapy in chronic brain syndrome. McQuillan LM; Lopec CA; Vibal JR Curr Ther Res Clin Exp; 1974 Jan; 16(1):49-58. PubMed ID: 4203848 [No Abstract] [Full Text] [Related]
10. Effect of cyclandelate on dementia. Westreich G; Alter M; Lundgren S Stroke; 1975; 6(5):535-8. PubMed ID: 1101457 [TBL] [Abstract][Full Text] [Related]
11. Papaverin in the treatment of geriatric patients. Bambasová E; Bílková J; Budínská K Act Nerv Super (Praha); 1974 Aug; 16(3):191-2. PubMed ID: 4609360 [No Abstract] [Full Text] [Related]
12. Effect of papaverine on cerebral electrogenesis. Culebras A Neurology; 1976 Jul; 26(7):673-9. PubMed ID: 778656 [TBL] [Abstract][Full Text] [Related]
13. [Results of Paveron 75 therapy in negatively selected patients with cerebral function disorders]. Klaus P; Wiethaup H Med Welt; 1973 Sep; 24(37):1413-4. PubMed ID: 4587961 [No Abstract] [Full Text] [Related]
14. [Therapy of cerebral insufficiency]. Grill P; Broicher H Dtsch Med Wochenschr; 1969 Nov; 94(47):2429-35. PubMed ID: 4981669 [No Abstract] [Full Text] [Related]
15. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study. Bazo AJ J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704 [No Abstract] [Full Text] [Related]
16. Drugs for mental disorders of old age. Hollister LE JAMA; 1975 Oct; 234(2):195-8. PubMed ID: 240950 [No Abstract] [Full Text] [Related]
17. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency]. Komorovskaia IaM; Nechaĭ EE Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974 [TBL] [Abstract][Full Text] [Related]
18. The clinical use of piracetam, a new nootropic drug. The treatment of symptoms of senile involution. Stegink AJ Arzneimittelforschung; 1972 Jun; 22(6):975-7. PubMed ID: 4559159 [No Abstract] [Full Text] [Related]
19. The management of cerebral atherosclerosis. Stern FH Psychosomatics; 1968; 9(4):229-34. PubMed ID: 4233303 [No Abstract] [Full Text] [Related]
20. [Experience with the use of pangamic acid (vitamin B-15) in arteriosclerosis of the vessels of the brain with mental disorders]. Rastopchin IP Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(2):264-7. PubMed ID: 5439840 [No Abstract] [Full Text] [Related] [Next] [New Search]